nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—Pentostatin—Floxuridine—stomach cancer	0.326	0.448	CrCrCtD
Adenosine—Cladribine—Floxuridine—stomach cancer	0.206	0.283	CrCrCtD
Adenosine—Decitabine—Floxuridine—stomach cancer	0.196	0.269	CrCrCtD
Adenosine—DPP4—blood vessel—stomach cancer	0.00355	0.0619	CbGeAlD
Adenosine—SLC28A3—pancreas—stomach cancer	0.00298	0.052	CbGeAlD
Adenosine—SLC28A3—digestive system—stomach cancer	0.00255	0.0444	CbGeAlD
Adenosine—ADA—hematopoietic system—stomach cancer	0.00239	0.0416	CbGeAlD
Adenosine—SLC28A3—bone marrow—stomach cancer	0.00235	0.0409	CbGeAlD
Adenosine—ADORA2B—smooth muscle tissue—stomach cancer	0.0023	0.0401	CbGeAlD
Adenosine—ADORA2A—hematopoietic system—stomach cancer	0.00217	0.0379	CbGeAlD
Adenosine—ADK—hematopoietic system—stomach cancer	0.00195	0.034	CbGeAlD
Adenosine—DPP4—hematopoietic system—stomach cancer	0.00189	0.033	CbGeAlD
Adenosine—ADORA1—hematopoietic system—stomach cancer	0.00187	0.0327	CbGeAlD
Adenosine—DPP4—epithelium—stomach cancer	0.00173	0.0301	CbGeAlD
Adenosine—ADK—smooth muscle tissue—stomach cancer	0.00172	0.0299	CbGeAlD
Adenosine—ADA—lymphoid tissue—stomach cancer	0.00168	0.0293	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—stomach cancer	0.00166	0.029	CbGeAlD
Adenosine—ADA—digestive system—stomach cancer	0.00166	0.0289	CbGeAlD
Adenosine—ADK—pancreas—stomach cancer	0.00159	0.0277	CbGeAlD
Adenosine—DPP4—pancreas—stomach cancer	0.00154	0.0268	CbGeAlD
Adenosine—ADA—bone marrow—stomach cancer	0.00153	0.0267	CbGeAlD
Adenosine—ADORA2A—lymphoid tissue—stomach cancer	0.00153	0.0267	CbGeAlD
Adenosine—ADK—lymphoid tissue—stomach cancer	0.00137	0.0239	CbGeAlD
Adenosine—ADA—endocrine gland—stomach cancer	0.00137	0.0239	CbGeAlD
Adenosine—DPP4—lymphoid tissue—stomach cancer	0.00133	0.0232	CbGeAlD
Adenosine—DPP4—digestive system—stomach cancer	0.00131	0.0229	CbGeAlD
Adenosine—ADK—bone marrow—stomach cancer	0.00125	0.0218	CbGeAlD
Adenosine—ADORA2A—endocrine gland—stomach cancer	0.00125	0.0218	CbGeAlD
Adenosine—DPP4—bone marrow—stomach cancer	0.00121	0.0211	CbGeAlD
Adenosine—Adenosine monophosphate—FBP1—stomach cancer	0.0012	0.171	CrCbGaD
Adenosine—Adenosine monophosphate—PRKAB1—stomach cancer	0.0012	0.171	CrCbGaD
Adenosine—ADORA2A—liver—stomach cancer	0.00112	0.0196	CbGeAlD
Adenosine—ADK—endocrine gland—stomach cancer	0.00112	0.0195	CbGeAlD
Adenosine—DPP4—endocrine gland—stomach cancer	0.00109	0.0189	CbGeAlD
Adenosine—ADORA1—endocrine gland—stomach cancer	0.00108	0.0188	CbGeAlD
Adenosine—ADK—liver—stomach cancer	0.00101	0.0176	CbGeAlD
Adenosine—Cytarabine—NT5E—stomach cancer	0.00101	0.143	CrCbGaD
Adenosine—DPP4—liver—stomach cancer	0.000979	0.0171	CbGeAlD
Adenosine—ADA—lymph node—stomach cancer	0.000948	0.0165	CbGeAlD
Adenosine—Azacitidine—DNMT1—stomach cancer	0.00081	0.115	CrCbGaD
Adenosine—Decitabine—DNMT1—stomach cancer	0.000791	0.113	CrCbGaD
Adenosine—ADK—lymph node—stomach cancer	0.000774	0.0135	CbGeAlD
Adenosine—DPP4—lymph node—stomach cancer	0.000751	0.0131	CbGeAlD
Adenosine—ADORA1—lymph node—stomach cancer	0.000745	0.013	CbGeAlD
Adenosine—Adenosine monophosphate—PRKAA1—stomach cancer	0.000689	0.0981	CrCbGaD
Adenosine—Adenosine triphosphate—PRKAA1—stomach cancer	0.000597	0.0851	CrCbGaD
Adenosine—Glucosamine—MMP9—stomach cancer	0.000439	0.0625	CrCbGaD
Adenosine—Glucosamine—TNF—stomach cancer	0.000289	0.0411	CrCbGaD
Adenosine—Bronchospasm—Docetaxel—stomach cancer	0.000276	0.00294	CcSEcCtD
Adenosine—Back pain—Irinotecan—stomach cancer	0.000273	0.00291	CcSEcCtD
Adenosine—Bronchospasm—Capecitabine—stomach cancer	0.000267	0.00284	CcSEcCtD
Adenosine—Abdominal discomfort—Capecitabine—stomach cancer	0.00026	0.00277	CcSEcCtD
Adenosine—Vision blurred—Fluorouracil—stomach cancer	0.000255	0.00272	CcSEcCtD
Adenosine—Syncope—Irinotecan—stomach cancer	0.000253	0.0027	CcSEcCtD
Adenosine—Loss of consciousness—Irinotecan—stomach cancer	0.000248	0.00265	CcSEcCtD
Adenosine—Cough—Irinotecan—stomach cancer	0.000247	0.00263	CcSEcCtD
Adenosine—Acute coronary syndrome—Docetaxel—stomach cancer	0.000246	0.00263	CcSEcCtD
Adenosine—Myocardial infarction—Docetaxel—stomach cancer	0.000245	0.00261	CcSEcCtD
Adenosine—Hypertension—Irinotecan—stomach cancer	0.000244	0.0026	CcSEcCtD
Adenosine—Acute coronary syndrome—Capecitabine—stomach cancer	0.000239	0.00254	CcSEcCtD
Adenosine—Cerebrovascular accident—Methotrexate—stomach cancer	0.000239	0.00254	CcSEcCtD
Adenosine—Discomfort—Irinotecan—stomach cancer	0.000238	0.00253	CcSEcCtD
Adenosine—Myocardial infarction—Capecitabine—stomach cancer	0.000237	0.00253	CcSEcCtD
Adenosine—Convulsion—Fluorouracil—stomach cancer	0.000234	0.0025	CcSEcCtD
Adenosine—Anaphylactic shock—Irinotecan—stomach cancer	0.000231	0.00246	CcSEcCtD
Adenosine—Chest pain—Fluorouracil—stomach cancer	0.00023	0.00246	CcSEcCtD
Adenosine—Discomfort—Fluorouracil—stomach cancer	0.000228	0.00243	CcSEcCtD
Adenosine—Shock—Irinotecan—stomach cancer	0.000227	0.00242	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—stomach cancer	0.000224	0.00239	CcSEcCtD
Adenosine—Hypoaesthesia—Docetaxel—stomach cancer	0.000223	0.00238	CcSEcCtD
Adenosine—Cerebrovascular accident—Epirubicin—stomach cancer	0.000223	0.00238	CcSEcCtD
Adenosine—Hyperhidrosis—Irinotecan—stomach cancer	0.000223	0.00238	CcSEcCtD
Adenosine—Mood swings—Methotrexate—stomach cancer	0.000221	0.00236	CcSEcCtD
Adenosine—Bradycardia—Capecitabine—stomach cancer	0.000221	0.00236	CcSEcCtD
Adenosine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000221	0.00235	CcSEcCtD
Adenosine—Hypoaesthesia—Capecitabine—stomach cancer	0.000216	0.0023	CcSEcCtD
Adenosine—Tachycardia—Fluorouracil—stomach cancer	0.000216	0.0023	CcSEcCtD
Adenosine—Hypotension—Irinotecan—stomach cancer	0.000215	0.0023	CcSEcCtD
Adenosine—Affect lability—Epirubicin—stomach cancer	0.000215	0.00229	CcSEcCtD
Adenosine—Flushing—Docetaxel—stomach cancer	0.000208	0.00222	CcSEcCtD
Adenosine—Cardiac disorder—Docetaxel—stomach cancer	0.000208	0.00222	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—stomach cancer	0.000208	0.00222	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—stomach cancer	0.000207	0.00221	CcSEcCtD
Adenosine—Mood swings—Epirubicin—stomach cancer	0.000207	0.00221	CcSEcCtD
Adenosine—Paraesthesia—Irinotecan—stomach cancer	0.000207	0.00221	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000207	0.0022	CcSEcCtD
Adenosine—Hypotension—Fluorouracil—stomach cancer	0.000206	0.0022	CcSEcCtD
Adenosine—Dyspnoea—Irinotecan—stomach cancer	0.000206	0.00219	CcSEcCtD
Adenosine—Somnolence—Irinotecan—stomach cancer	0.000205	0.00218	CcSEcCtD
Adenosine—Tinnitus—Capecitabine—stomach cancer	0.000203	0.00216	CcSEcCtD
Adenosine—Mediastinal disorder—Docetaxel—stomach cancer	0.000202	0.00215	CcSEcCtD
Adenosine—Flushing—Capecitabine—stomach cancer	0.000202	0.00215	CcSEcCtD
Adenosine—Cardiac disorder—Capecitabine—stomach cancer	0.000202	0.00215	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000201	0.00214	CcSEcCtD
Adenosine—Arrhythmia—Docetaxel—stomach cancer	0.0002	0.00214	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—stomach cancer	0.000199	0.00212	CcSEcCtD
Adenosine—Paraesthesia—Fluorouracil—stomach cancer	0.000198	0.00211	CcSEcCtD
Adenosine—Pain—Irinotecan—stomach cancer	0.000197	0.0021	CcSEcCtD
Adenosine—Dyspnoea—Fluorouracil—stomach cancer	0.000197	0.0021	CcSEcCtD
Adenosine—Somnolence—Fluorouracil—stomach cancer	0.000196	0.00209	CcSEcCtD
Adenosine—Mediastinal disorder—Capecitabine—stomach cancer	0.000196	0.00209	CcSEcCtD
Adenosine—Arrhythmia—Capecitabine—stomach cancer	0.000194	0.00207	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—stomach cancer	0.000194	0.00206	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—stomach cancer	0.000192	0.00205	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—stomach cancer	0.000192	0.00204	CcSEcCtD
Adenosine—Dysgeusia—Docetaxel—stomach cancer	0.000191	0.00204	CcSEcCtD
Adenosine—Back pain—Docetaxel—stomach cancer	0.000189	0.00201	CcSEcCtD
Adenosine—Pain—Fluorouracil—stomach cancer	0.000189	0.00201	CcSEcCtD
Adenosine—Dysgeusia—Capecitabine—stomach cancer	0.000185	0.00197	CcSEcCtD
Adenosine—Back pain—Capecitabine—stomach cancer	0.000183	0.00195	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—stomach cancer	0.00018	0.00192	CcSEcCtD
Adenosine—Vision blurred—Capecitabine—stomach cancer	0.000178	0.0019	CcSEcCtD
Adenosine—Tremor—Capecitabine—stomach cancer	0.000177	0.00189	CcSEcCtD
Adenosine—Urticaria—Fluorouracil—stomach cancer	0.000175	0.00187	CcSEcCtD
Adenosine—Syncope—Docetaxel—stomach cancer	0.000175	0.00187	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—stomach cancer	0.000175	0.00186	CcSEcCtD
Adenosine—Sweating—Methotrexate—stomach cancer	0.000173	0.00184	CcSEcCtD
Adenosine—Palpitations—Docetaxel—stomach cancer	0.000173	0.00184	CcSEcCtD
Adenosine—Loss of consciousness—Docetaxel—stomach cancer	0.000172	0.00183	CcSEcCtD
Adenosine—Cough—Docetaxel—stomach cancer	0.00017	0.00182	CcSEcCtD
Adenosine—Hypersensitivity—Irinotecan—stomach cancer	0.00017	0.00181	CcSEcCtD
Adenosine—Syncope—Capecitabine—stomach cancer	0.00017	0.00181	CcSEcCtD
Adenosine—Convulsion—Docetaxel—stomach cancer	0.000169	0.0018	CcSEcCtD
Adenosine—Hypertension—Docetaxel—stomach cancer	0.000169	0.0018	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—stomach cancer	0.000169	0.0018	CcSEcCtD
Adenosine—Palpitations—Capecitabine—stomach cancer	0.000167	0.00178	CcSEcCtD
Adenosine—Chest pain—Docetaxel—stomach cancer	0.000166	0.00177	CcSEcCtD
Adenosine—Loss of consciousness—Capecitabine—stomach cancer	0.000166	0.00177	CcSEcCtD
Adenosine—Asthenia—Irinotecan—stomach cancer	0.000165	0.00176	CcSEcCtD
Adenosine—Cough—Capecitabine—stomach cancer	0.000165	0.00176	CcSEcCtD
Adenosine—Hypertension—Capecitabine—stomach cancer	0.000163	0.00174	CcSEcCtD
Adenosine—Hypersensitivity—Fluorouracil—stomach cancer	0.000163	0.00173	CcSEcCtD
Adenosine—Dry mouth—Docetaxel—stomach cancer	0.000163	0.00173	CcSEcCtD
Adenosine—Sweating—Epirubicin—stomach cancer	0.000162	0.00172	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—stomach cancer	0.000162	0.00172	CcSEcCtD
Adenosine—Chest pain—Capecitabine—stomach cancer	0.000161	0.00172	CcSEcCtD
Adenosine—Anxiety—Capecitabine—stomach cancer	0.00016	0.00171	CcSEcCtD
Adenosine—Anaphylactic shock—Docetaxel—stomach cancer	0.000159	0.0017	CcSEcCtD
Adenosine—Discomfort—Capecitabine—stomach cancer	0.000159	0.0017	CcSEcCtD
Adenosine—Dry mouth—Capecitabine—stomach cancer	0.000157	0.00168	CcSEcCtD
Adenosine—Shock—Docetaxel—stomach cancer	0.000157	0.00167	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—stomach cancer	0.000156	0.00166	CcSEcCtD
Adenosine—Tachycardia—Docetaxel—stomach cancer	0.000156	0.00166	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—stomach cancer	0.000154	0.00164	CcSEcCtD
Adenosine—Dizziness—Irinotecan—stomach cancer	0.000152	0.00162	CcSEcCtD
Adenosine—Shock—Capecitabine—stomach cancer	0.000152	0.00162	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—stomach cancer	0.000151	0.00161	CcSEcCtD
Adenosine—Tachycardia—Capecitabine—stomach cancer	0.000151	0.00161	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—stomach cancer	0.000151	0.0016	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—stomach cancer	0.00015	0.0016	CcSEcCtD
Adenosine—Sweating—Doxorubicin—stomach cancer	0.00015	0.00159	CcSEcCtD
Adenosine—Hyperhidrosis—Capecitabine—stomach cancer	0.000149	0.00159	CcSEcCtD
Adenosine—Hypotension—Docetaxel—stomach cancer	0.000149	0.00159	CcSEcCtD
Adenosine—Vomiting—Irinotecan—stomach cancer	0.000147	0.00156	CcSEcCtD
Adenosine—Dizziness—Fluorouracil—stomach cancer	0.000146	0.00156	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—stomach cancer	0.000146	0.00155	CcSEcCtD
Adenosine—Rash—Irinotecan—stomach cancer	0.000145	0.00155	CcSEcCtD
Adenosine—Dermatitis—Irinotecan—stomach cancer	0.000145	0.00155	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000145	0.00155	CcSEcCtD
Adenosine—Headache—Irinotecan—stomach cancer	0.000144	0.00154	CcSEcCtD
Adenosine—Hypotension—Capecitabine—stomach cancer	0.000144	0.00154	CcSEcCtD
Adenosine—Paraesthesia—Docetaxel—stomach cancer	0.000143	0.00153	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—stomach cancer	0.000143	0.00152	CcSEcCtD
Adenosine—Dyspnoea—Docetaxel—stomach cancer	0.000142	0.00151	CcSEcCtD
Adenosine—Somnolence—Docetaxel—stomach cancer	0.000142	0.00151	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—stomach cancer	0.000141	0.0015	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000141	0.0015	CcSEcCtD
Adenosine—Flushing—Epirubicin—stomach cancer	0.00014	0.0015	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—stomach cancer	0.00014	0.0015	CcSEcCtD
Adenosine—Vomiting—Fluorouracil—stomach cancer	0.00014	0.0015	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000139	0.00148	CcSEcCtD
Adenosine—Rash—Fluorouracil—stomach cancer	0.000139	0.00148	CcSEcCtD
Adenosine—Dermatitis—Fluorouracil—stomach cancer	0.000139	0.00148	CcSEcCtD
Adenosine—Paraesthesia—Capecitabine—stomach cancer	0.000139	0.00148	CcSEcCtD
Adenosine—Headache—Fluorouracil—stomach cancer	0.000138	0.00147	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—stomach cancer	0.000138	0.00147	CcSEcCtD
Adenosine—Dyspnoea—Capecitabine—stomach cancer	0.000138	0.00147	CcSEcCtD
Adenosine—Nausea—Irinotecan—stomach cancer	0.000137	0.00146	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—stomach cancer	0.000136	0.00145	CcSEcCtD
Adenosine—Pain—Docetaxel—stomach cancer	0.000136	0.00145	CcSEcCtD
Adenosine—Back pain—Methotrexate—stomach cancer	0.000136	0.00145	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—stomach cancer	0.000135	0.00144	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—stomach cancer	0.000133	0.00141	CcSEcCtD
Adenosine—Pain—Capecitabine—stomach cancer	0.000132	0.00141	CcSEcCtD
Adenosine—Nausea—Fluorouracil—stomach cancer	0.000131	0.0014	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—stomach cancer	0.000131	0.00139	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—stomach cancer	0.00013	0.00138	CcSEcCtD
Adenosine—Flushing—Doxorubicin—stomach cancer	0.00013	0.00138	CcSEcCtD
Adenosine—Tension—Epirubicin—stomach cancer	0.000129	0.00138	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—stomach cancer	0.000129	0.00137	CcSEcCtD
Adenosine—Nervousness—Epirubicin—stomach cancer	0.000128	0.00136	CcSEcCtD
Adenosine—Back pain—Epirubicin—stomach cancer	0.000127	0.00136	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000126	0.00134	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—stomach cancer	0.000125	0.00133	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—stomach cancer	0.000124	0.00132	CcSEcCtD
Adenosine—Cough—Methotrexate—stomach cancer	0.000123	0.00131	CcSEcCtD
Adenosine—Urticaria—Capecitabine—stomach cancer	0.000123	0.00131	CcSEcCtD
Adenosine—Convulsion—Methotrexate—stomach cancer	0.000122	0.0013	CcSEcCtD
Adenosine—Agitation—Epirubicin—stomach cancer	0.000121	0.00129	CcSEcCtD
Adenosine—Chest pain—Methotrexate—stomach cancer	0.00012	0.00128	CcSEcCtD
Adenosine—Tension—Doxorubicin—stomach cancer	0.00012	0.00127	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—stomach cancer	0.000119	0.00127	CcSEcCtD
Adenosine—Discomfort—Methotrexate—stomach cancer	0.000118	0.00126	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Adenosine—Syncope—Epirubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Adenosine—Back pain—Doxorubicin—stomach cancer	0.000118	0.00126	CcSEcCtD
Adenosine—Hypersensitivity—Docetaxel—stomach cancer	0.000117	0.00125	CcSEcCtD
Adenosine—Palpitations—Epirubicin—stomach cancer	0.000116	0.00124	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—stomach cancer	0.000116	0.00123	CcSEcCtD
Adenosine—Cough—Epirubicin—stomach cancer	0.000115	0.00123	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—stomach cancer	0.000115	0.00122	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—stomach cancer	0.000115	0.00122	CcSEcCtD
Adenosine—Asthenia—Docetaxel—stomach cancer	0.000114	0.00122	CcSEcCtD
Adenosine—Convulsion—Epirubicin—stomach cancer	0.000114	0.00122	CcSEcCtD
Adenosine—Hypertension—Epirubicin—stomach cancer	0.000114	0.00121	CcSEcCtD
Adenosine—Hypersensitivity—Capecitabine—stomach cancer	0.000114	0.00121	CcSEcCtD
Adenosine—Chest pain—Epirubicin—stomach cancer	0.000112	0.0012	CcSEcCtD
Adenosine—Agitation—Doxorubicin—stomach cancer	0.000112	0.00119	CcSEcCtD
Adenosine—Anxiety—Epirubicin—stomach cancer	0.000112	0.00119	CcSEcCtD
Adenosine—Hyperhidrosis—Methotrexate—stomach cancer	0.000111	0.00118	CcSEcCtD
Adenosine—Discomfort—Epirubicin—stomach cancer	0.000111	0.00118	CcSEcCtD
Adenosine—Asthenia—Capecitabine—stomach cancer	0.000111	0.00118	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—stomach cancer	0.00011	0.00117	CcSEcCtD
Adenosine—Syncope—Doxorubicin—stomach cancer	0.000109	0.00116	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—stomach cancer	0.000108	0.00115	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—stomach cancer	0.000108	0.00115	CcSEcCtD
Adenosine—Hypotension—Methotrexate—stomach cancer	0.000107	0.00114	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—stomach cancer	0.000107	0.00114	CcSEcCtD
Adenosine—Cough—Doxorubicin—stomach cancer	0.000106	0.00113	CcSEcCtD
Adenosine—Shock—Epirubicin—stomach cancer	0.000106	0.00113	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—stomach cancer	0.000106	0.00113	CcSEcCtD
Adenosine—Dizziness—Docetaxel—stomach cancer	0.000105	0.00112	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—stomach cancer	0.000105	0.00112	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—stomach cancer	0.000105	0.00112	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000105	0.00112	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—stomach cancer	0.000104	0.00111	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—stomach cancer	0.000104	0.00111	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—stomach cancer	0.000103	0.0011	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—stomach cancer	0.000103	0.0011	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—stomach cancer	0.000103	0.00109	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—stomach cancer	0.000102	0.00109	CcSEcCtD
Adenosine—Somnolence—Methotrexate—stomach cancer	0.000102	0.00109	CcSEcCtD
Adenosine—Dizziness—Capecitabine—stomach cancer	0.000102	0.00109	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—stomach cancer	0.000101	0.00108	CcSEcCtD
Adenosine—Vomiting—Docetaxel—stomach cancer	0.000101	0.00108	CcSEcCtD
Adenosine—Rash—Docetaxel—stomach cancer	0.000101	0.00107	CcSEcCtD
Adenosine—Hypotension—Epirubicin—stomach cancer	0.0001	0.00107	CcSEcCtD
Adenosine—Dermatitis—Docetaxel—stomach cancer	0.0001	0.00107	CcSEcCtD
Adenosine—Headache—Docetaxel—stomach cancer	9.99e-05	0.00106	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—stomach cancer	9.95e-05	0.00106	CcSEcCtD
Adenosine—Pain—Methotrexate—stomach cancer	9.82e-05	0.00105	CcSEcCtD
Adenosine—Vomiting—Capecitabine—stomach cancer	9.81e-05	0.00105	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—stomach cancer	9.8e-05	0.00104	CcSEcCtD
Adenosine—Shock—Doxorubicin—stomach cancer	9.79e-05	0.00104	CcSEcCtD
Adenosine—Rash—Capecitabine—stomach cancer	9.73e-05	0.00104	CcSEcCtD
Adenosine—Dermatitis—Capecitabine—stomach cancer	9.72e-05	0.00104	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—stomach cancer	9.71e-05	0.00103	CcSEcCtD
Adenosine—Headache—Capecitabine—stomach cancer	9.67e-05	0.00103	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—stomach cancer	9.65e-05	0.00103	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—stomach cancer	9.62e-05	0.00102	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—stomach cancer	9.59e-05	0.00102	CcSEcCtD
Adenosine—Somnolence—Epirubicin—stomach cancer	9.56e-05	0.00102	CcSEcCtD
Adenosine—Nausea—Docetaxel—stomach cancer	9.47e-05	0.00101	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—stomach cancer	9.3e-05	0.000991	CcSEcCtD
Adenosine—Pain—Epirubicin—stomach cancer	9.19e-05	0.00098	CcSEcCtD
Adenosine—Nausea—Capecitabine—stomach cancer	9.17e-05	0.000977	CcSEcCtD
Adenosine—Urticaria—Methotrexate—stomach cancer	9.13e-05	0.000973	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.06e-05	0.000966	CcSEcCtD
Adenosine—Paraesthesia—Doxorubicin—stomach cancer	8.93e-05	0.000952	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—stomach cancer	8.87e-05	0.000945	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—stomach cancer	8.84e-05	0.000942	CcSEcCtD
Adenosine—Urticaria—Epirubicin—stomach cancer	8.54e-05	0.00091	CcSEcCtD
Adenosine—Pain—Doxorubicin—stomach cancer	8.51e-05	0.000907	CcSEcCtD
Adenosine—Hypersensitivity—Methotrexate—stomach cancer	8.46e-05	0.000902	CcSEcCtD
Adenosine—Asthenia—Methotrexate—stomach cancer	8.24e-05	0.000878	CcSEcCtD
Adenosine—Hypersensitivity—Epirubicin—stomach cancer	7.92e-05	0.000844	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—stomach cancer	7.9e-05	0.000842	CcSEcCtD
Adenosine—Asthenia—Epirubicin—stomach cancer	7.71e-05	0.000822	CcSEcCtD
Adenosine—Dizziness—Methotrexate—stomach cancer	7.6e-05	0.00081	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—stomach cancer	7.33e-05	0.000781	CcSEcCtD
Adenosine—Vomiting—Methotrexate—stomach cancer	7.3e-05	0.000778	CcSEcCtD
Adenosine—Rash—Methotrexate—stomach cancer	7.24e-05	0.000772	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—stomach cancer	7.24e-05	0.000771	CcSEcCtD
Adenosine—Headache—Methotrexate—stomach cancer	7.2e-05	0.000767	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—stomach cancer	7.14e-05	0.000761	CcSEcCtD
Adenosine—Dizziness—Epirubicin—stomach cancer	7.11e-05	0.000758	CcSEcCtD
Adenosine—Vomiting—Epirubicin—stomach cancer	6.84e-05	0.000728	CcSEcCtD
Adenosine—Nausea—Methotrexate—stomach cancer	6.82e-05	0.000727	CcSEcCtD
Adenosine—Rash—Epirubicin—stomach cancer	6.78e-05	0.000722	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—stomach cancer	6.77e-05	0.000722	CcSEcCtD
Adenosine—Headache—Epirubicin—stomach cancer	6.74e-05	0.000718	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—stomach cancer	6.58e-05	0.000701	CcSEcCtD
Adenosine—Nausea—Epirubicin—stomach cancer	6.39e-05	0.000681	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—stomach cancer	6.33e-05	0.000674	CcSEcCtD
Adenosine—Rash—Doxorubicin—stomach cancer	6.27e-05	0.000668	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—stomach cancer	6.27e-05	0.000668	CcSEcCtD
Adenosine—Headache—Doxorubicin—stomach cancer	6.23e-05	0.000664	CcSEcCtD
Adenosine—Nausea—Doxorubicin—stomach cancer	5.91e-05	0.00063	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—CXCL8—stomach cancer	3.7e-05	0.000323	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AGTR2—stomach cancer	3.67e-05	0.00032	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ADRB1—stomach cancer	3.63e-05	0.000318	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—F2R—stomach cancer	3.63e-05	0.000317	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—stomach cancer	3.55e-05	0.00031	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HTR1A—stomach cancer	3.53e-05	0.000308	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGG—stomach cancer	3.51e-05	0.000306	CbGpPWpGaD
Adenosine—ADK—Metabolism—CAV1—stomach cancer	3.48e-05	0.000304	CbGpPWpGaD
Adenosine—ADK—Metabolism—APOA1—stomach cancer	3.48e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1B—stomach cancer	3.47e-05	0.000303	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—ADRB2—stomach cancer	3.46e-05	0.000303	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKAB1—stomach cancer	3.44e-05	0.000301	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—stomach cancer	3.43e-05	0.000299	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ANXA1—stomach cancer	3.41e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PPP2R1A—stomach cancer	3.39e-05	0.000297	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKAA1—stomach cancer	3.38e-05	0.000295	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—stomach cancer	3.38e-05	0.000295	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—stomach cancer	3.38e-05	0.000295	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KISS1—stomach cancer	3.32e-05	0.00029	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RNF43—stomach cancer	3.32e-05	0.00029	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.31e-05	0.000289	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ADRB1—stomach cancer	3.3e-05	0.000288	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AGTR2—stomach cancer	3.3e-05	0.000288	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HSPB1—stomach cancer	3.3e-05	0.000288	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RBP4—stomach cancer	3.26e-05	0.000285	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—F2R—stomach cancer	3.26e-05	0.000285	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BMP2—stomach cancer	3.26e-05	0.000285	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—stomach cancer	3.26e-05	0.000285	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPP2R1A—stomach cancer	3.22e-05	0.000282	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKR1C3—stomach cancer	3.21e-05	0.00028	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1A—stomach cancer	3.2e-05	0.00028	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—stomach cancer	3.19e-05	0.000279	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HTR1A—stomach cancer	3.18e-05	0.000277	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTP1—stomach cancer	3.16e-05	0.000276	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK8—stomach cancer	3.13e-05	0.000273	CbGpPWpGaD
Adenosine—ADA—Metabolism—HMOX1—stomach cancer	3.12e-05	0.000272	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PRKCB—stomach cancer	3.07e-05	0.000269	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ANXA1—stomach cancer	3.07e-05	0.000268	CbGpPWpGaD
Adenosine—ADK—Metabolism—PPARG—stomach cancer	3.06e-05	0.000268	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADRB1—stomach cancer	2.97e-05	0.000259	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FST—stomach cancer	2.96e-05	0.000259	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ADRB2—stomach cancer	2.95e-05	0.000257	CbGpPWpGaD
Adenosine—ADA—Metabolism—TYMS—stomach cancer	2.94e-05	0.000257	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—stomach cancer	2.93e-05	0.000256	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTM1—stomach cancer	2.91e-05	0.000254	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HBEGF—stomach cancer	2.9e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—stomach cancer	2.89e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GAST—stomach cancer	2.86e-05	0.00025	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RGS2—stomach cancer	2.86e-05	0.00025	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—STAT3—stomach cancer	2.86e-05	0.00025	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RPS6—stomach cancer	2.84e-05	0.000248	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HSPB1—stomach cancer	2.8e-05	0.000245	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AGTR2—stomach cancer	2.8e-05	0.000245	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PRKCB—stomach cancer	2.79e-05	0.000244	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6ST—stomach cancer	2.78e-05	0.000243	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BMP2—stomach cancer	2.77e-05	0.000242	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—F2R—stomach cancer	2.77e-05	0.000242	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALB—stomach cancer	2.75e-05	0.000241	CbGpPWpGaD
Adenosine—ADA—Metabolism—ERCC2—stomach cancer	2.73e-05	0.000239	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK3—stomach cancer	2.73e-05	0.000238	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKR1C3—stomach cancer	2.73e-05	0.000238	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—stomach cancer	2.71e-05	0.000237	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGG—stomach cancer	2.71e-05	0.000237	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HTR1A—stomach cancer	2.7e-05	0.000236	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ADRB2—stomach cancer	2.67e-05	0.000234	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—stomach cancer	2.65e-05	0.000231	CbGpPWpGaD
Adenosine—ADK—Metabolism—NOS3—stomach cancer	2.64e-05	0.00023	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PPP2R1A—stomach cancer	2.62e-05	0.000229	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PRKCB—stomach cancer	2.61e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HBEGF—stomach cancer	2.61e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKAA1—stomach cancer	2.61e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ANXA1—stomach cancer	2.61e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK1—stomach cancer	2.6e-05	0.000227	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—stomach cancer	2.6e-05	0.000227	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—stomach cancer	2.59e-05	0.000227	CbGpPWpGaD
Adenosine—ADA—Metabolism—MTHFR—stomach cancer	2.57e-05	0.000224	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRB1—stomach cancer	2.53e-05	0.000221	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RBP4—stomach cancer	2.52e-05	0.00022	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—stomach cancer	2.52e-05	0.00022	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6R—stomach cancer	2.48e-05	0.000217	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—RHOA—stomach cancer	2.47e-05	0.000216	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—stomach cancer	2.45e-05	0.000214	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RPS6—stomach cancer	2.41e-05	0.000211	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—stomach cancer	2.41e-05	0.000211	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADRB2—stomach cancer	2.41e-05	0.00021	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PRKCB—stomach cancer	2.37e-05	0.000207	CbGpPWpGaD
Adenosine—ADA—Metabolism—CAV1—stomach cancer	2.37e-05	0.000207	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6ST—stomach cancer	2.36e-05	0.000207	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOA1—stomach cancer	2.36e-05	0.000206	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PPP2R1A—stomach cancer	2.36e-05	0.000206	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—stomach cancer	2.25e-05	0.000197	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—RHOA—stomach cancer	2.24e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HBEGF—stomach cancer	2.22e-05	0.000194	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SMAD4—stomach cancer	2.19e-05	0.000191	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—stomach cancer	2.17e-05	0.000189	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HSPB1—stomach cancer	2.17e-05	0.000189	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGTR2—stomach cancer	2.17e-05	0.000189	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—F2R—stomach cancer	2.14e-05	0.000187	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BMP2—stomach cancer	2.14e-05	0.000187	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6R—stomach cancer	2.11e-05	0.000184	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1C3—stomach cancer	2.11e-05	0.000184	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—RHOA—stomach cancer	2.1e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—stomach cancer	2.09e-05	0.000182	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR1A—stomach cancer	2.08e-05	0.000182	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARG—stomach cancer	2.08e-05	0.000182	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FYN—stomach cancer	2.08e-05	0.000182	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRB2—stomach cancer	2.05e-05	0.000179	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PRKCB—stomach cancer	2.02e-05	0.000176	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ANXA1—stomach cancer	2.01e-05	0.000176	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PPP2R1A—stomach cancer	2.01e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—stomach cancer	2e-05	0.000174	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—stomach cancer	1.97e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGFR2—stomach cancer	1.95e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRB1—stomach cancer	1.95e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RHOA—stomach cancer	1.91e-05	0.000166	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—stomach cancer	1.87e-05	0.000164	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RPS6—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMAD4—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—stomach cancer	1.84e-05	0.000161	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PRKCB—stomach cancer	1.83e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6ST—stomach cancer	1.83e-05	0.000159	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—stomach cancer	1.79e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS2—stomach cancer	1.79e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FYN—stomach cancer	1.77e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CAV1—stomach cancer	1.73e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOA1—stomach cancer	1.73e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HBEGF—stomach cancer	1.71e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—stomach cancer	1.67e-05	0.000146	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR2—stomach cancer	1.66e-05	0.000145	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PRKCB—stomach cancer	1.65e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6ST—stomach cancer	1.64e-05	0.000144	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—stomach cancer	1.64e-05	0.000143	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6R—stomach cancer	1.63e-05	0.000142	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—RHOA—stomach cancer	1.62e-05	0.000142	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRB2—stomach cancer	1.58e-05	0.000138	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APC—stomach cancer	1.58e-05	0.000138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP2R1A—stomach cancer	1.55e-05	0.000135	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS2—stomach cancer	1.52e-05	0.000133	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK3—stomach cancer	1.51e-05	0.000132	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—stomach cancer	1.48e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CAV1—stomach cancer	1.47e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RHOA—stomach cancer	1.47e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOA1—stomach cancer	1.47e-05	0.000128	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6R—stomach cancer	1.47e-05	0.000128	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK1—stomach cancer	1.44e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—stomach cancer	1.44e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMAD4—stomach cancer	1.44e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—stomach cancer	1.42e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKCB—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6ST—stomach cancer	1.4e-05	0.000122	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—stomach cancer	1.37e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SERPINE1—stomach cancer	1.37e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FYN—stomach cancer	1.36e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—stomach cancer	1.36e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APC—stomach cancer	1.34e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RHOA—stomach cancer	1.32e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—stomach cancer	1.31e-05	0.000114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—stomach cancer	1.29e-05	0.000113	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK3—stomach cancer	1.29e-05	0.000112	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR2—stomach cancer	1.28e-05	0.000112	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—stomach cancer	1.25e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6R—stomach cancer	1.25e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—stomach cancer	1.23e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK1—stomach cancer	1.22e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—stomach cancer	1.22e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS2—stomach cancer	1.17e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—stomach cancer	1.17e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SERPINE1—stomach cancer	1.17e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—stomach cancer	1.16e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—stomach cancer	1.16e-05	0.000101	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—stomach cancer	1.15e-05	0.000101	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CAV1—stomach cancer	1.14e-05	9.94e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1B—stomach cancer	1.14e-05	9.92e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOA1—stomach cancer	1.14e-05	9.92e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RHOA—stomach cancer	1.13e-05	9.83e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—stomach cancer	1.11e-05	9.73e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—stomach cancer	1.11e-05	9.65e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—stomach cancer	1.08e-05	9.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCB—stomach cancer	1.08e-05	9.46e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—stomach cancer	1.08e-05	9.44e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6ST—stomach cancer	1.08e-05	9.42e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—stomach cancer	1.06e-05	9.27e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—stomach cancer	1.05e-05	9.18e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1A—stomach cancer	1.05e-05	9.15e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—stomach cancer	1.04e-05	9.1e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APC—stomach cancer	1.04e-05	9.05e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK8—stomach cancer	1.02e-05	8.93e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—stomach cancer	1.01e-05	8.8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK3—stomach cancer	9.92e-06	8.67e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—stomach cancer	9.88e-06	8.63e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—stomach cancer	9.82e-06	8.58e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1B—stomach cancer	9.65e-06	8.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6R—stomach cancer	9.62e-06	8.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK1—stomach cancer	9.44e-06	8.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—stomach cancer	9.44e-06	8.25e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—stomach cancer	9.44e-06	8.25e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—stomach cancer	9.4e-06	8.21e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—stomach cancer	9.35e-06	8.16e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—stomach cancer	9.21e-06	8.04e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—stomach cancer	9.19e-06	8.03e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—stomach cancer	9.02e-06	7.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SERPINE1—stomach cancer	9.01e-06	7.87e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—stomach cancer	8.94e-06	7.81e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK3—stomach cancer	8.93e-06	7.8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—stomach cancer	8.92e-06	7.79e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1A—stomach cancer	8.91e-06	7.78e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK8—stomach cancer	8.69e-06	7.59e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RHOA—stomach cancer	8.69e-06	7.59e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—stomach cancer	8.69e-06	7.59e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—stomach cancer	8.6e-06	7.51e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK1—stomach cancer	8.5e-06	7.42e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—stomach cancer	8.5e-06	7.42e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—stomach cancer	8.19e-06	7.16e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—stomach cancer	8.05e-06	7.03e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—stomach cancer	8.03e-06	7.01e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—stomach cancer	8.03e-06	7.01e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—stomach cancer	7.95e-06	6.94e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—stomach cancer	7.63e-06	6.67e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK3—stomach cancer	7.59e-06	6.63e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—stomach cancer	7.58e-06	6.62e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1B—stomach cancer	7.45e-06	6.51e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—stomach cancer	7.39e-06	6.45e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—stomach cancer	7.37e-06	6.44e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—stomach cancer	7.26e-06	6.34e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK1—stomach cancer	7.22e-06	6.31e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—stomach cancer	7.22e-06	6.31e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—stomach cancer	7.13e-06	6.23e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—stomach cancer	7.11e-06	6.21e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—stomach cancer	7.09e-06	6.2e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—stomach cancer	6.9e-06	6.03e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1A—stomach cancer	6.88e-06	6.01e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—stomach cancer	6.82e-06	5.96e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—stomach cancer	6.82e-06	5.96e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK8—stomach cancer	6.71e-06	5.86e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—stomach cancer	6.53e-06	5.7e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—stomach cancer	6.27e-06	5.48e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—stomach cancer	6.2e-06	5.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—stomach cancer	6.14e-06	5.36e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—stomach cancer	6.06e-06	5.3e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK3—stomach cancer	5.86e-06	5.12e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—stomach cancer	5.8e-06	5.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—stomach cancer	5.7e-06	4.98e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK1—stomach cancer	5.58e-06	4.87e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—stomach cancer	5.58e-06	4.87e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—stomach cancer	5.55e-06	4.85e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—stomach cancer	5.27e-06	4.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—stomach cancer	4.84e-06	4.23e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—stomach cancer	4.68e-06	4.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—stomach cancer	4.48e-06	3.91e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—stomach cancer	4.29e-06	3.74e-05	CbGpPWpGaD
